AP NEWS

The Clinical Diagnostics Market - Global Growth Trends & Opportunities to 2023 featuring Abbott Labs, bioMerieux, Bio-Rad Labs, Danaher Corp, Qiagen, Roche Diagnostics, Siemens, and Thermo Fisher - ResearchAndMarkets.com

September 26, 2018

DUBLIN--(BUSINESS WIRE)--Sep 26, 2018--The “Global Clinical Diagnostic Market - Segmented by Test, Product (Instrument, Reagent, and Data Management Systems), End User, and Geography - Growth, Trends, and Forecast (2018-2023)” report has been added to ResearchAndMarkets.com’s offering.

The clinical diagnostic market is expected to register a growth rate of nearly 5.2% over the forecast period, 2018-2023.

The healthcare industry has experienced substantial growth in the clinical diagnostic market. The clinical diagnostic market is growing with the increasing adoption of POC diagnostics, owing to ease-of-use and ability to provide instant results, combined with ease-of-procurement.

North America is estimated to dominate the clinical diagnostic market, due to growing prevalence of chronic diseases, increasing burden of infectious diseases, and rising adoption of advanced technologies.

Increasing Incidences of Infectious and Chronic Diseases Boost the Growth of the Clinical Diagnostic Market

Other factors contributing to the clinical diagnostic market are, the increasing adoption of the automated platform and rising number of private hospitals and independent testing laboratories.

Cumbersome Reimbursement Procedure Limits the Growth of the Clinical Diagnostic Market

Additionally, affordability for high-end molecular diagnostics and stringent regulations across the world is also restraining the clinical diagnostic market.

Key Developments in the Market

Thermo Fisher Scientific launched TSQ Fortis Triple Quadrupole Mass Spectrometer, which offers robust and fast analysis with LC-MS/MS for Clinical Research Laboratories. Thermo Fisher Scientific launched B - R - A - H - M - S PCT direct blood test, which allows fast bacterial infection and sepsis diagnosis at patient’s point-of-care.

Companies Profiled

Abbott Laboratories Becton, Dickinson and Company bioMerieux Bio-Rad Laboratories Inc. Danaher Corporation Diasorin Hologic Inc. Ortho Clinical Diagnostics Qiagen Roche Diagnostics Siemens AG Thermo Fisher Scientific

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Company Profiles and Competitive Landscape

9. The Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/qb98v5/the_clinical?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180926005372/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/26/2018 05:47 AM/DISC: 09/26/2018 05:47 AM

http://www.businesswire.com/news/home/20180926005372/en

AP RADIO
Update hourly